Evidence map›Paper›PMID 36100995›Full record

ArticleCardiovascular & hematological disorders drug targets2022

The Association Between Hematologic Indices with TIMI Flow in STEMI Patients who Undergo Primary Percutaneous Coronary Intervention.

Saeed Alipour Parsa, Saeed Nourian, Morteza Safi, Mohammad Hasan Namazi, Habib Saadat, Hossein Vakili, Vahid Eslami, Ayoub Salehi, Farshid Heidarpour Kiaee, Nasim Sohrabifar and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Cardiovascular & hematological disorders drug targets, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Saeed Alipour ParsaCardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Saeed NourianCardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Morteza SafiCardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mohammad Hasan NamaziCardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Habib SaadatCardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Hossein VakiliCardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Vahid EslamiCardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Ayoub SalehiCardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Farshid Heidarpour KiaeeCardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Nasim SohrabifarCardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Isa KhaheshiCardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Primary Percutaneous Coronary Intervention (PPCI) is the preferred therapeutic strategy for patients who experienced ST-Elevation Myocardial Infarction (STEMI).

objectiveWe aimed to evaluate the association of hematological indices, including hemoglobin level, platelets, White Blood Cells (WBCs) count, and MPV before PPCI with the TIMI grade flow after PPCI.

methodsSTEMI patients who experienced PPCI were included in the present retrospective crosssectional study. Then participants were divided into three groups based on their post-procedural TIMI flow grades. Demographic data and hematologic indices of patients before PPCI were collected and their association with the TIMI grade flow after PPCI was evaluated. To compare the quantitative and qualitative variables, chi-square and t-tests were performed, respectively.

resultsWe found that elevated levels of hemoglobin and decreased levels of MPV had a significant association with an advanced grade of TIMI flow. Interestingly, in the normal range, there was a significant association between higher platelet count and TIMI-flow grade 1. Besides, TIMI flow grades 2 and 3 had a significant association with low and moderate platelets count, respectively.

conclusionIn conclusion, evaluating MPV, platelets, and hemoglobin levels before PPCI as easy and accessible parameters may be able to identify high-risk STEMI patients undergoing PPCI.

Indexed as

adverse outcomehematologic indices.PPCIprognosisSTEMITIMI-flow grade

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.